UBS Group AG executives recently met with officials from President Donald Trump’s administration as they evaluate a potential strategy shift that could help the Swiss bank combat stiffer capital requirements at home, the New York Post reported on Sunday. Steps could include the purchase of a US bank or a merger, the newspaper said, citing sources it didn’t identify. UBS, when contacted by Bloomberg for a response to the report, referred to recent comments by Chief Executive Officer Sergio Ermotti that it ...

Banking giant UBS is ramping up its threats to leave Switzerland and set up shop in the US — a radical response to Swiss regulators who have proposed onerous new capital requirements on the financial behemoth, The Post has learned.Executives at the 162-year-old Swiss bank — led by highly regarded Chairman Colm Kelleher and CEO Sergio Ermotti — have even recently met with Trump administration officials to prepare for the possible seismic strategy shift that could include the purchase of a US bank or a merger ...

外资流入规模 - 8月中国股票（在岸、离岸合计）录得自2024年9月以来最大规模的月度净买入 [1][2] - 高盛Prime账户对中国资产总配置环比上升76个基点至6.4%创近两年新高 净配置增加173个基点至8.6% [2] - 韩国股民对中国股票（A股、港股合计）持仓总额达35亿美元 较去年同期增长近五成 [2] 外资配置方向 - 科技成长、高股息资产和高端制造成为外资重点布局方向 [1][6] - 北向资金在信息技术与工业板块主要流入 金融板块持续受青睐 [5] - 外资对港股市场布局集中在科技、金融及部分消费与制造领域 科技成长、医疗保健及生物技术方向持股集中度较高 [6] 资金流入方式 - 外资通过A股ETF和指数期货快速切入中国股票市场 [3][4] - 1月至9月北向资金对互联互通机制下ETF累计成交额达5122亿元 超过2024年全年的4640亿元 [4] - 7月北向资金投资互联互通机制下ETF日均成交额达32.82亿元 环比增长近四成 [4] 板块交易活跃度 - 华夏上证科创板50ETF日均成交额达35.31亿元位居首位 华泰柏瑞沪深300ETF以32.08亿元紧随其后 [4] - 南方红利低波50ETF获34.58亿元净流入 华泰柏瑞中证红利低波ETF获27.96亿元净流入 [5] - 华宝中证金融科技主题ETF净流入27.56亿元 嘉实上证科创板芯片ETF净流入27.08亿元 [5] 外资配置逻辑变化 - 行业偏好从防御转向进攻 传统消费让位于科技成长与高端制造 [6] - 政策与估值成为驱动因素 低估值的科技龙头与分红稳定的银行股受关注 [6] - 自7月以来科技、医疗与材料等板块成为外资重点加仓对象 尤其是AI产业链相关公司 [6] 外资兴趣提升原因 - 中国在机器人、生物医药等领域领先地位使全球资产配置难以回避中国市场 [3] - 稳经济政策释放积极信号 市场流动性状况显著改善 [1][3] - 超过九成受访美国投资者明确表示将增加对中国市场敞口 比例创2021年初以来新高 [2]

(Bloomberg) -- Switzerland appointed a well-established military careerist as the chief of its armed forces, a role that will involve resolving controversies and a string of procurement issues that marred the term of his predecessor. Major General Benedikt Roos, 60, currently commands the army’s territorial divisions and will start his new role on Jan. 1, the government said Friday. He will succeed Thomas Suessli, who announced his resignation in February. The appointment of Roos — a career officer since ...

智通财经APP获悉，瑞银集团已将金价预测上调至2025年底达到每盎司3800美元，2026年中达到3900美 元，理由是美国劳动力数据疲软背景下预计美联储将重新降息。 这家投资银行还预期美元走弱及持续的地缘政治不确定性将推动投资者需求增长，市场参与者正将黄金 作为对冲工具。 瑞银分析师表示："从投资组合的角度来看，多元化配置和持有相关对冲资产至关重要。"他们补充称， 美国总统特朗普希望降低政策利率也提升了黄金的吸引力。 "我们对黄金保持看好观点，并在全球资产配置中维持黄金多头头寸。此外，我们的分析表明，配置中 个位数百分比的黄金是最优选择。" 黄金已重拾上涨势头，年内迄今涨幅达38%，当前价格略低于本月早些时候创下的每盎司3674美元的历 史高点。截至发稿时，金价上涨0.3%，报每盎司3644.43美元。 ...

金价预测上调 - 高盛将2029年起长期金价预测从2850美元/盎司上调至3300美元/盎司 [1] - 高盛认为金价存在上行至4500-5000美元/盎司的风险 [1] - 瑞银将2025年底金价预测上调300美元至3800美元/盎司 [4] - 瑞银将2026年中期金价预测上调200美元至3900美元/盎司 [4] 黄金股表现 - 高盛认为黄金股将在2025年继续跑赢大宗商品本身 [3] - 澳大利亚黄金行业市值从700亿澳元增至1350亿澳元 [3] - 全球黄金巨头市值从1350亿美元扩大到2700亿美元 [3] - 利润率扩张是黄金股表现优异的关键驱动力 [3] 机构观点与配置 - 高盛全球大宗商品团队仍看好黄金 [1] - 瑞银对黄金保持"有吸引力"看法并在全球资产配置中继续做多 [4] - 瑞银认为中等个位数的百分比配置对黄金是最佳的 [4] - 纽蒙特公司被高盛评为中性但具有积极产量/自由现金流/资本管理前景 [2] 支撑因素分析 - 预期美联储宽松政策及美元疲软支撑金价 [4] - 地缘政治风险增加黄金吸引力 [4] - 央行黄金购买量预计保持在900-950吨强劲水平 [4] - 黄金ETF持有量预计2025年底超过3900吨接近历史纪录 [4] 市场表现数据 - 现货黄金创下3674.85美元/盎司历史新高 [4] - 黄金价格年初至今上涨超过39% [4] - 周五欧盘时段黄金价格在3648-3649美元区间高位徘徊 [5]

Neon-lit Hong Kong skyline with Chainlink, UBS, and DigiFT logos linked by glowing smart-contract rails to tokenized fund cubes and a vault, symbolizing automated distribution under Cyberport A new collaboration between Chainlink Labs, UBS Asset Management, and DigiFT is aiming to overhaul how investment funds are created and managed. The three firms announced on Sept. 11 that they are building an automated framework for tokenized products under Hong Kong’s Cyberport program. The Cyberport Blockchain & ...

[角色] 你是一名拥有10年投资银行从业经验的资深研究分析师，专门负责上市公司、行业研究。你擅长解读公司财报、行业动态、宏观市场，发现潜在的投资机会和风险。 [任务] 你需要仔细研读一份上市公司或者行业研究的电话会议记录，请阅读全文，一步一步思考，总结全文列出关键要点，不要错过任何信息，包括： * 纪要涉及的行业或者公司 * 纪要提到的核心观点和论据 * 其他重要但是可能被忽略的内容 如果没有相关内容，请跳过这一部分，进行其他的部分。 总结时要全面、详细、尽可能覆盖全部的内容、不遗漏重点,并根据上述方面对内容进行分组。 要引用原文数字数据和百分比变化,注意单位换算(billion=十亿,million=百万,thousand=千)。 [注意事项] 1) 使用中文,不要出现句号 2) 采用markdown格式 3) 不使用第一人称,以"公司"、"行业"代替 4) 只输出关于公司和行业的内容 5) 在每一个关键点后用[序号]形式引用原文档id 6) 一个[序号]只应该包含一个数字，不能包含多个，如果多个就用[序号][序号]分开写，不要写成 [序号-序号] 7) 每个关键要点后边的 [序号] 不要超过 3 个 Content: --------- <doc id='1'>ab 7 September 2025</doc> <doc id='2'>First Read Global Oil Fundamentals OPEC+ to push further OPEC+ partners to keep raising production in October The eight OPEC+ members carrying out the second tranche of voluntary cuts of 1.65Mb/ d announced on Sunday that they will raise oil production by 137kb/d in October (link). This will continue the production increases after the group fully unwinds the previous 2.2Mb/d voluntary cuts by the end of September, in only six months. The October run rate implies a return of 1.65Mb/d over one year but the group emphasised that any further adjustment remains contingent on evolving market conditions. The oil price had already dropped last week on reports that the group would continue raising production (link), limiting the immediate impact, but we would still expect the decision to weigh on prices. The next meeting is scheduled for 5 October.</doc> <doc id='3'>Actual production increase likely to be even lower than for the first tranche Even more than for the first tranche of production cuts, we expect the actual production increase from this second tranche to fall short of the headline number. We estimate that only around 40% of the 1.65Mb/d is likely to materialise, compared to a ~60% increase for the previous 2.2Mb/d. We expect the bulk of this increase to be driven by Saudi Arabia (500kb/d) and the UAE (144kb/d). This is due to a combination of countries already producing above target and in some cases limited ability to increase production further. See Figure 2 for full breakdown of the 1.65Mb/d.</doc> <doc id='4'>Still, even larger surplus looms, higher risk of <$60/bbl This weekend's announcement reinforces our caution on oil prices near-term (UBSe $62/ bbl Brent in 4Q25/1Q26). We were already projecting much larger surpluses in the oil market over the next few months in our last monthly update: 1.2Mb/d in 4Q25 and 2.4Mb/d in 1Q26, before the October increase. If OPEC+ partners continue at this pace over the next few months, the surplus would rise to ~2.7Mb/d. This has the potential to bring prices below our base case and push Brent sub-$60/bbl in our view. The decision could prove to be supportive in the longer term as it could show that real spare capacity within the group is more limited now and reduce non-OPEC supply growth.</doc> <doc id='5'>Equities Global Oil Companies, Major Henri Patricot, CFA Analyst henri.patricot@ubs.com +33-14-888 3033 Nayoung Kim Analyst nayoung.kim@ubs.com +44-20-7568 4010 Joshua Stone Analyst joshua.stone@ubs.com +44-20-7901 5588 Josh Silverstein Analyst josh.silverstein@ubs.com +1-212-713 3513 Tom Allen Analyst tom.allen@ubs.com +61-3-9242 6237 Tasso Vasconcellos Analyst tasso.vasconcellos@ubs.com +55-11-2767 6683 This report has been prepared by UBS Europe SE. ANALYST CERTIFICATION AND REQUIRED DISCLOSURES, including information on the Quantitative Research Review published by UBS, begin on page 5. UBS does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.</doc> <doc id='6'>-500 0 500 1,000 1,500 2,000 2,500 3,000 3,500 Apr-25 Jul-25 Oct-25 Jan-26 Apr-26 Jul-26 Oct-26 Russia Oman Kazakhstan UAE Saudi Arabia Kuwait Iraq Algeria Cumulative increase UBSe cumulative increase Cumulative increase without compensation UBSe vs. March target level</doc> <doc id='7'>Figure 1: Planned gradual return of the voluntary cuts (cumulative increase, kb/d)</doc> <doc id='8'>Source: OPEC, UBS. Note: includes the 300kb/d UAE quota increase and the announced October 2025 increase, but no increase beyond October 2025.</doc> <doc id='9'>| Figure 2: Split of the October increase and second tranche of voluntary cuts | | --- | | kb/d | October increase | Share of the 1.65Mb/d cuts | | --- | --- | --- | | Saudi Arabia | 42 | 500 | | UAE | 12 | 144 | | Russia | 42 | 500 | | Iraq | 17 | 211 | | Kuwait | 11 | 128 | | Kazakhstan | 6 | 78 | | Algeria | 4 | 48 | | Oman | 3 | 40 | | | 137 | 1649 | Source: OPEC.</doc> <doc id='10'>Figure 3: Quarterly global oil supply and demand balance (Mb/d)</doc> <doc id='11'>98 100 102 104 106 108 110 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 2Q22 4Q22 2Q23 4Q23 2Q24 4Q24 2Q25 4Q25E 2Q26E 4Q26E Oil demand/supply balance (Mb/d) Stock changes (Mb/d) Implied over/ (under) supply Demand Supply</doc> <doc id='12'>Source: IEA, UBSe.</doc> <doc id='13'>-200 -100 0 100 200 300 400 500 Jan-24 Apr-24 Jul-24 Oct-24 Jan-25 Apr-25 Jul-25 Iraq Kazakhstan Russia</doc> <doc id='14'>Figure 4: Production gap to targets for the 3 OPEC+ members due to implement compensation plans, based on OPEC secondary sources (kb/d) Source: OPEC, UBS.</doc> <doc id='15'>Valuation Method and Risk Statement In history, oil prices have proved consistently unpredictable because so many political, geological, and economic trends and events affect the supply of and demand for oil. Oil prices are extremely volatile in the short, medium and long term, as they are frequently affected by inherently unpredictable events, including natural disasters.</doc> <doc id='16'>Required Disclosures This document has been prepared by UBS Europe SE, an affiliate of UBS AG. UBS AG, its subsidiaries, branches and affiliates, including former Credit Suisse AG and its subsidiaries, branches and affiliates are referred to herein as "UBS".</doc> <doc id='17'>For information on the ways in which UBS manages conflicts and maintains independence of its UBS Global Research product; historical performance information; certain additional disclosures concerning UBS Global Research recommendations; and terms and conditions for certain third party data used in research report, please visit https://www.ubs.com/disclosures. Unless otherwise indicated, information and data in this report are based on company disclosures including but not limited to annual, interim, quarterly reports and other company announcements. The figures contained in performance charts refer to the past; past performance is not a reliable indicator of future results. Additional information will be made available upon request. UBS Securities Co. Limited is licensed to conduct securities investment consultancy businesses by the China Securities Regulatory Commission. UBS acts or may act as principal in the debt securities (or in related derivatives) that may be the subject of this report. This recommendation was finalized on: 07 September 2025 07:00 PM GMT. UBS has designated certain UBS Global Research department members as Derivatives Research Analysts where those department members publish research principally on the analysis of the price or market for a derivative, and provide information reasonably sufficient upon which to base a decision to enter into a derivatives transaction. Where Derivatives Research Analysts co-author research reports with Equity Research Analysts or Economists, the Derivatives Research Analyst is responsible for the derivatives investment views, forecasts, and/or recommendations. Quantitative Research Review: UBS Global Research publishes a quantitative assessment of its analysts' responses to certain questions about the likelihood of an occurrence of a number of short term factors in a product known as the 'Quantitative Research Review'. Views contained in this assessment on a particular stock reflect only the views on those short term factors which are a different timeframe to the 12-month timeframe reflected in any equity rating set out in this note. For the latest responses, please see the Quantitative Research Review Addendum at the back of this report, where applicable. For previous responses please make reference to (i) previous UBS Global Research reports; and (ii) where no applicable research report was published that month, the Quantitative Research Review which can be found at https:// neo.ubs.com/quantitative, or contact your UBS sales representative for access to the report or the Quantitative Research Team on ubs- quant-answers@ubs.com. A consolidated report which contains all responses is also available and again you should contact your UBS sales representative for details and pricing or the Quantitative Research team on the email above.</doc> <doc id='18'>Analyst Certification: Each research analyst primarily responsible for the content of this research report, in whole or in part, certifies that with respect to each security or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about those securities or issuers and were prepared in an independent manner, including with respect to UBS, and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by that research analyst in the research report.</doc> <doc id='19'>| 12-Month Rating | Definition | Coverage1 | IB Services2 | | | --- | --- | --- | --- | --- | | Buy | FSR is > 6% above the MRA. | 52% | | 22% | | Neutral | FSR is between -6% and 6% of the MRA. | 41% | | 20% | | Sell | FSR is > 6% below the MRA. | 8% | | 22% | | Short-Term Rating | Definition | Coverage3 | IB Services4 | | | Buy | Stock price expected to rise within three months from the time the rating was assigned because of a specific catalyst or event. | <1% | | <1% | | Sell | Stock price expected to fall within three months from the time the rating was assigned because of a specific catalyst or event. | <1% | | <1% |</doc> <doc id='20'>UBS Global Research: Global Equity Rating Definitions</doc> <doc id='21'>Source: UBS. Rating allocations are as of 30 June 2025. 1:Percentage of companies under coverage globally within the 12-month rating category. 2:Percentage of companies within the 12-month rating category for which investment banking (IB) services were provided within the past 12 months. 3:Percentage of companies under coverage globally within the Short-Term rating category.</doc> <doc id='22'>4:Percentage of companies within the Short-Term rating category for which investment banking (IB) services were provided within the past 12 months.</doc> <doc id='23'>KEY DEFINITIONS:Forecast Stock Return (FSR) is defined as expected percentage price appreciation plus gross dividend yield over the next 12 months. In some cases, this yield may be based on accrued dividends. Market Return Assumption (MRA) is defined as the one-year local market interest rate plus 5% (a proxy for, and not a forecast of, the equity risk premium). Under Review (UR) Stocks may be flagged as UR by the analyst, indicating that the stock's price target and/or rating are subject to possible change in the near term, usually in response to an event that may affect the investment case or valuation. Equity Price Targets have an investment horizon of 12 months.</doc> <doc id='24'>EXCEPTIONS AND SPECIAL CASES:UK and European Investment Fund ratings and definitions are: Buy: Positive on factors such as structure, management, performance record, discount; Neutral: Neutral on factors such as structure, management, performance record, discount; Sell: Negative on factors such as structure, management, performance record, discount. Core Banding Exceptions (CBE): Exceptions to the standard +/-6% bands may be granted by the Investment Review Consultation (IRC). Factors considered by the IRC include the stock's volatility and the credit spread of the respective company's debt. As a result, stocks deemed to be very high or low risk may be subject to higher or lower bands as they relate to the rating. When such exceptions apply, they will be identified in the Company Disclosures table in the relevant research piece.</doc> <doc id='25'>Research analysts contributing to this report who are employed by any non-US affiliate of UBS Securities LLC are not registered/ qualified as research analysts with FINRA. Such analysts may not be associated persons of UBS Securities LLC and therefore are not subject to the FINRA restrictions on communications with a subject company, public appearances, and trading securities held by a research analyst account. The name of each affiliate and analyst employed by that affiliate contributing to this report, if any, follows.</doc> <doc id='26'>UBS AG London Branch: Joshua Stone, Nayoung Kim.UBS BB Corretora de Câmbio, Títulos e Valores Mobiliários S.A.: Tasso Vasconcellos.UBS Europe SE: Henri Patricot, CFA.UBS Securities Australia Ltd: Tom Allen.UBS Securities LLC: Josh Silverstein.</doc> <doc id='27'>Unless otherwise indicated, please refer to the Valuation and Risk sections within the body of this report. For a complete set of disclosure statements associated with the companies discussed in this report, including information on valuation and risk, please contact UBS Securities LLC, 11 Madison Avenue, New York, NY 10010, USA, Attention: Investment Research.</doc> <doc id='28'>The Disclaimer relevant to Global Wealth Management clients follows the Global Research Disclaimer. The Disclaimer relevant to Credit Suisse Wealth Management follows the Global Wealth Management Disclaimer. UBS Global Research Disclaimer This document has been prepared by UBS Europe SE, an affiliate of UBS AG. UBS AG, its subsidiaries, branches and affiliates, including former Credit Suisse AG and its subsidiaries, branches and affiliates are referred to herein as "UBS".</doc> <doc id='29'>Any opinions expressed in this document may change without notice and are only current as of the date of publication. Different areas, groups, and personnel within UBS may produce and distribute separate research products independently of each other. For example, research publications from UBS CIO are produced by UBS Global Wealth Management. UBS Global Research is produced by UBS Investment Bank. Research methodologies and rating systems of each separate research organization may differ, for example, in terms of investment recommendations, investment horizon, model assumptions, and valuation methods. As a consequence, except for certain economic forecasts (for which UBS CIO and UBS Global Research may collaborate), investment recommendations, ratings, price targets, and valuations provided by by each of the separate research organizations may be different, or inconsistent. You should refer to each relevant research product for the details as to their methodologies and rating system. Not all clients may have access to all products from every organization. Each research product is subject to the policies and procedures of the organization that produces it.</doc> <doc id='30'>This document is provided solely to recipients who are expressly authorized by UBS to receive it. If you are not so authorized you must immediately destroy the document. UBS Global Research is provided to our clients through UBS Neo, and in certain instances, UBS.com and any other system or distribution method specifically identified in one or more communications distributed through UBS Neo or UBS.com (each a system) as an approved means for distributing UBS Global Research. It may also be made available through third party vendors and distributed by UBS and/or third parties via e-mail or alternative electronic means.</doc> <doc id='31'>All UBS Global Research is available on UBS Neo. Please contact your UBS sales representative if you wish to discuss your access to UBS Neo. Where UBS Global Research refers to "UBS Evidence Lab Inside" or has made use of data provided by UBS Evidence Lab and you would like to access that data please contact your UBS sales representative. UBS Evidence Lab data is available on UBS Neo. The level and types of services provided by UBS Global Research and UBS Evidence Lab to a client may vary depending upon various factors such as a client's individual preferences as to the frequency and manner of receiving communications, a client's risk profile and investment focus and

核心观点 - 瑞银CIO报告筛选出5大最具吸引力长期投资主题 包括数字消费者 多元化与平等 赋能技术 金融科技和发掘下一个前沿市场 其中发掘下一个前沿市场首次进入前五 金融科技从第五名提升[5][6] - 报告建议短期减少对基因疗法和医疗科技敞口 因缺乏积极催化剂 但智能出行主题因估值与动量改善可重新关注[6][15][16] - 长期投资底层逻辑基于三大不可逆趋势：人口增长（2050年达97亿） 城市化（2050年占比68%）和老龄化（2050年每6人中有1人≥65岁）[19] 数字消费者主题 - 投资逻辑：Z世代等数字原住民更重体验共享而非实物拥有 数字化增加消费决策触点 AI颠覆传统领域 元宇宙和社交媒体构成核心机会[8] - 入场理由：排名第一 质量优势包括企业资产负债表稳健和投入资本回报率高 科技板块反弹带动动量提升 但估值相对较高[8] 多元化与平等主题 - 投资逻辑：全球监管推动企业披露多元化数据 提升多元化可缩小财富鸿沟并拉动GDP增长 股东关注度飙升使多元化企业长期跑赢市场[9][10] - 入场理由：估值合理且质量得分高 跨行业分散兼具防御 价值和成长属性 需警惕美国部分州法律挑战风险[10] 赋能技术主题 - 投资逻辑：生成式AI加速技术融合 重点看好AI AR/VR 大数据 5G和突破性技术 这些技术重构多个行业 软硬件占比高推动低双位数盈利增长[11] - 入场理由：动量突出且估值有吸引力 高度聚焦IT板块 2030年AI市场规模达2.6万亿美元 2024-2030年CAGR为41%[11] 金融科技主题 - 投资逻辑：城市化 年轻群体需求和政策支持推动行业收入从2024年3100亿美元增至2030年5800亿美元 关注头部支付企业 平台型公司及新兴技术颠覆者[12] - 入场理由：动量持续改善 契合看好美国金融板块观点 估值暴跌后业务重构为盈利增长 AI进步和低利率周期优化行业环境[12] 发掘下一个前沿市场主题 - 投资逻辑：新兴及前沿经济体是全球GDP增长核心动力 2024年十大发展中经济体人口占比超50% 部分市场能将经济增长转化为企业盈利增长[13] - 入场理由：美国财政赤字扩大和美元走弱提升吸引力 投资者分散美国资产敞口 利率下降利好新兴市场股票 全球经济韧性提供支撑[13] 短期谨慎主题 - 基因疗法：生物科技行业面临资本约束 融资泡沫破裂后现金流承压 投资者情绪低迷 临床研发与商业化受阻[15] - 医疗科技：估值基于数字颠覆预期而非实际商业模式 需证明盈利与规模化能力 用户增长难转化收益 医保报销和监管障碍导致落地慢[15] - 智能出行：脱离谨慎名单 因估值与动量改善 汽车脱碳为长期趋势 短期利好包括IAA车展展示电动化和自动驾驶进展 行业估值过低[16] 长期趋势 - 人口增长：全球人口从2024年81亿增至2050年97亿 2100年或超100亿 增长主要来自中低收入国家[19] - 城市化：全球城市人口占比从1950年30%升至2018年55% 2050年达68% 90%增长来自亚洲和非洲[19] - 老龄化：2024年每10人中有1人≥65岁 2050年升至每6人1人 发达国家更严重达每4人1人[19] 投资建议 - 分散布局多主题以降低回撤风险[26] - 坚持长期投资避免频繁交易 核心驱动如AI和新兴市场增长为长期趋势[26] - 警惕投资风险 咨询专业顾问[26]

中国期货市场开放进程 - 2025年以来监管层连续三次推出开放措施 合格境外投资者可参与的期货期权品种数量已扩容至104个 开放力度前所未有 [1][8] - 开放品种覆盖九成市场流动性 其中商品期货47个 众多仅在中国上市的大宗商品可被QFII交易 [9] - 期货市场境外客户较2022年同期增长63% 目前已有全球39个国家或地区交易者参与 [11] 瑞银期货战略定位与业务发展 - 作为中国最早一批外资控股期货公司 始终站在开放进程第一线 积极推动境外投资者参与中国市场 [2] - 2016年实现瑞银全资控股 2025年4月瑞银集团实现对瑞银证券全资控股 成为中国首家外商独资全牌照证券公司 [3] - 对标全球标准落地先进风险管理架构 提供定制化服务 包括前置风险提示、套保期现匹配、持仓限额管理等 [6] 业务创新与里程碑事件 - 2022年完成QFII/RQFII首单国内商品期货交易 成为首家支持QFII参与境内商品期货市场的期货公司 [6] - 2023年以来提供连续交易服务、境外中介业务、国债质押保证金业务等新业务 [6] - 2024年起在集团大中华区研讨会设立期货专题 面向数千名境外投资者系统介绍中国市场 [6] 市场机遇与投资者反应 - 2025年6月新增16个QFII可参与商品期货期权品种 10月9日起允许QFII参与场内ETF期权交易(涉及9个品种) [8] - 9月10日起新增开放石油沥青期货合约及燃料油、石油沥青、纸浆期权合约 [8] - 境外投资者在政策落地后第一时间展开交易 品种扩展极大激发投资兴趣 广泛欢迎资产配置、投资和风险对冲需求 [9] 国际化发展前景 - 陆家嘴论坛提出将优化QFII制度、拓展品种范围、推动人民币外汇期货和LNG期货期权等新品种上市 [9] - 未来3-5年合作与开放是主要趋势 中国期货市场将持续深化开放 实现与全球资本市场更高水平融合 [10] - 公司将聚焦高质量引入境外客户 发挥集团一体化优势 加强境内外协同 帮助客户理解中国市场制度与规则 [10]